Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 SignalingHee‐Bum Kang, Jing Chen, Daniel J. Brat et al.|Molecular Cell|2015Cited by 158
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation ConsortiumConor Steuer, Suresh S. Ramalingam, Madhusmita Behera et al.|Cancer|2015Cited by 118
Poly (<scp>ADP</scp>) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancerTaofeek K. Owonikoko, Shi‐Yong Sun, Guojing Zhang et al.|Cancer Medicine|2014Cited by 90
Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinomaMelissa Gilbert‐Ross, Adam I. Marcus, Jessica Konen et al.|JCI Insight|2017Cited by 71
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal MalignanciesKevin E. Fisher, Michael R. Rossi, Linsheng Zhang et al.|Journal of Molecular Diagnostics|2016Cited by 69